L Mészáros, F Lasch, B Delafont, L Guizzaro - Contemporary Clinical Trials …, 2024 - Elsevier
Background The estimands framework represents a significant innovation for the design, conduct, analysis, and interpretation of clinical trials. An aim of the framework is to increase …
K Wu, X Zhang, M Zheng, J Zhang… - Statistics in …, 2024 - Wiley Online Library
Hypothetical strategy is a common strategy for handling intercurrent events (IEs). No current guideline or study considers treatment–IE interaction to target the estimand in any one IE …
C Gower-Page, A Noci, M Wolbers - Journal of Open Source Software, 2022 - joss.theoj.org
Many randomized controlled clinical trials compare a continuous outcome variable that is assessed longitudinally at scheduled follow-up visits between subjects assigned to a …
The estimands framework outlined in ICH E9 (R1) describes the components needed to precisely define the effects to be estimated in clinical trials, which includes how post …
S Cro, JH Roger, JR Carpenter - Pharmaceutical statistics, 2024 - Wiley Online Library
ABSTRACT The ICH E9 (R1) Addendum (International Council for Harmonization 2019) suggests treatment‐policy as one of several strategies for addressing intercurrent events …
J Bell, T Drury, T Mütze, CB Pipper, L Guizzaro… - arXiv preprint arXiv …, 2024 - arxiv.org
Estimands using the treatment policy strategy for addressing intercurrent events are common in Phase III clinical trials. One estimation approach for this strategy is retrieved …
T Drury, JW Bartlett, D Wright, ON Keene - arXiv preprint arXiv:2412.12380, 2024 - arxiv.org
The creation of the ICH E9 (R1) estimands framework has led to more precise specification of the treatment effects of interest in the design and statistical analysis of clinical trials …
In clinical trials of longitudinal continuous outcomes, reference based imputation (RBI) has commonly been applied to handle missing outcome data in settings where the estimand …